We continue the Talks in the Cube with another expert discussion – the last event for 2025 focusses on Strategies to optimize the cooperation between the sponsor and Contract Research Organizations (CROs) when developing drugs in therapeutics and diagnostics.
A Panel Discussion with
Christopher Oelkrug, Director Business Development, Cytel GmbH, Berlin,
Dr. Andreas Hüser, MBA, CEO CheckImmune GmbH, Berlin,
Jan Tiedemann, Director Business Operations, Charité Research Organisation GmbH, Berlin,
Dr. Uwe Lohmeier, Berlin BioScience Academy (BBA), Campus Berlin Buch GmbH (Moderation).
Topics planned to be addressed
- Common approach: How to cooperate successfully
- Service selection: How to benefit from expertise
- Project Timing: When to start the collaboration
...and much more
...the talk will be followed by a networking event where you can socialize over snacks and drinks (sponsored by Cytel).
Christopher Oelkrug
acts currently as a Director of Business Development at Cytel and is primarily focused on identifying new opportunities with sponsors to provide a better clinical experience. Based on his broad experience in Cancer Immunotherapy and Immunology and his entrepreneurial mindset, Christopher brings a unique perspective to novel developments within these therapeutics fields. His focus lies on the translation of basic research into lifesaving therapies and acts as an interface between science and the industry. Christopher has a M.Sc. in Cancer Immunotherapy and is the holder of several patents in gut microbiome modulation and antibiotic resistance. Through his broad experience and global network in the Life Science field with over 15 years in the CRO industry including basic and applied research he is constantly identifying new trends.
Dr. Andreas Hüser
is a life sciences entrepreneur and innovation leader with extensive experience spanning biotechnology, clinical research, and business development. He is the CEO and Co-Founder of CheckImmune GmbH, a Berlin-based company specializing in biomarker development and analysis. Andreas has more than 25 years’ industry experience in the discovery and development of novel drugs. He was Co-Founder and Director, Project Management at Charité Research Organisation with responsibility for managing a multidisciplinary group, ensuring that collaborative early clinical research was executed to the highest standards. He has led teams working on numerous drug development projects for the biotech and pharmaceutical industry. Andreas worked as a Scientist in biotech industry before joining the contract research business in 2003 and holds a PhD in molecular biology from Humboldt University Berlin and a diploma degree in biotechnology from Technical University Berlin as well as a MBA in Entrepreneurial Management from Berlin School of Economics and Law.
Jan Tiedemann
has spent the last 10 years working in Business Operations for Charité Research Organisation, a 100% affiliate of Charité - Universitätsmedizin Berlin, after obtaining a master’s degree in Business Administration. Main functions in Business Operations for Charité Research Organisation include early sponsor engagement, sponsor relationship management, feasibility assessments for incoming study requests as well as budgeting and contracting. In this role he supported the conduct of more than 200 industry-sponsored trials from First-in-Human to Proof of Concept across a variety of therapeutic areas.
Dr. Uwe Lohmeier (Moderation)
Studied biology at the Freie Universität Berlin. PhD (Dr. rer. nat) in Plant Pathology at the Technische Universtität München. From 2001 – 2015 he worked as a Quality Manager in Clinical Development at Schering Pharma and Bayer AG. Since 2016 he has been at the Gläsernes Labor (GL) Buch at the GL Akademie (GLA) Management, now Berlin BioScience Academy (BBA) and lecturer at the Learning Lab. Since 2017 Uwe is Head of GLA / BBA.
Target audience
Founders & scientists from start-ups, small and medium-sized life science companies and scientific institutions.
Costs
Participation is free of charge. Registration is requested.
When
Thursday, 30 October 2025
5:00 p.m. - 7:00 p.m.
Where
BerlinBioCube (Building D95), Campus Berlin-Buch, Robert-Rössle-Straße 10, 13125 Berlin
Further information
Uwe Lohmeier per E-Mail: u.lohmeier@campusberlinbuch.de
About "Talk in the Cube"
With the event series "Talk in the Cube", we bring business and science together on the Berlin-Buch campus and connect founders of start-ups or life science companies with scientists, e.g. from the Max Delbrück Center, FMP, Charité and BIH. We invite experts on business topics or trends in the life sciences and highlight aspects such as
- What innovations are there in the start-ups and who is driving them forward?
- How does the life science business world work and where can synergies with science be created?
- How does the "networked laboratory" work and how do you live "sustainability in the laboratory"?
About the Berlin BioScience Academy "BBA"
The Berlin BioScience Academy (BBA), formerly known as "Gläsernes Labor Akademie (GLA)", supports young scientists throughout Germany in their professional orientation and entry into the pharmaceutical and biotechnology industry. It offers technical assistants and laboratory technicians in-service training on current topics in the life sciences.
Our focus is on a close connection between science and business. It enables the conception, certification and implementation of a practice-oriented continuing training program with a top-class team of experts from research institutions and industry.
The life science program includes summer schools, laboratory courses, seminars, webinars and congresses. In addition, the BBA invites to the "Talks in the Cube" at the BerlinBioCube. The talks regularly inform about "hot topics" in Biotech & Biomedicine and provide the campus network forum for biotech companies, research institutions, investors and associations.
Picture credits: P. Himsel
Version: 16 October 2025
Subject to modifications